๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Issues with the Use of Prostate-Specific Antigen as a Surrogate End Point in Hormone-Resistant Prostate Cancer

โœ Scribed by Don W.W. Newling

Book ID
118440597
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
232 KB
Volume
8
Category
Article
ISSN
1569-9056

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Can prostate-specific antigen be used as
Can prostate-specific antigen be used as a valid end point to determine the efficacy of chemotherapy for advanced prostate cancer?
โœ B. Seckin; C. T. Anthony; B. Murphy; M. S. Steiner ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 444 KB

It is current practice in many clinical trials evaluating new chemotherapy regimens for the treatment of advanced prostate cancer to use prostate-specific antigen (PSA) decline as a response criteria with the assumption that the level of PSA reflects the efficacy of chemotherapy. Advanced prostate c